Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Onofrio A. Catalano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7733-4138; OpenAlex author ID A5026625792. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 5

  1. Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Co-author DOI 10.7150/thno.100116↗
  2. Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000004585↗
  3. Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study. Last author DOI 10.1007/s11307-020-01569-7↗
  4. Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-020-04897-9↗
  5. Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoad… Co-author DOI 10.1245/s10434-020-09444-z↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Theodore Sunki Hong · 5 shared papers, 2021–2024 · strength 0.61
  2. Motaz Qadan · 5 shared papers, 2021–2024 · strength 0.61
  3. Colin D. Weekes · 4 shared papers, 2021–2024 · strength 0.49
  4. Cristina Rosa Ferrone · 4 shared papers, 2021–2022 · strength 0.46
  5. David Tsai Ting · 3 shared papers, 2021–2024 · strength 0.38
  6. Aparna R. Parikh · 3 shared papers, 2021–2024 · strength 0.38
  7. Carlos F. Fernandez-del Castillo · 3 shared papers, 2021–2022 · strength 0.35
  8. Vikram Deshpande · 3 shared papers, 2021–2022 · strength 0.35
  9. Jennifer Yon-Li Wo · 3 shared papers, 2021–2022 · strength 0.35
  10. Keith D. Lillemoe · 3 shared papers, 2021–2022 · strength 0.35
  11. David P. Ryan · 3 shared papers, 2021–2022 · strength 0.34
  12. Carlos Fernández-del Castillo · 2 shared papers, 2021–2024 · strength 0.26
  13. Yurie Sekigami · 2 shared papers, 2021 · strength 0.22
  14. Theodoros P. Michelakos · 2 shared papers, 2021 · strength 0.22
  15. Michael D. Lanuti · 1 shared paper, 2024 · strength 0.15
  16. Peter D. Caravan · 1 shared paper, 2024 · strength 0.15
  17. Shadi Abdar Esfahani · 1 shared paper, 2024 · strength 0.15
  18. Genevieve Marie Boland · 1 shared paper, 2024 · strength 0.15
  19. Hua Ma · 1 shared paper, 2024 · strength 0.15
  20. Kenneth K. Tanabe · 1 shared paper, 2024 · strength 0.15
  21. Hannah Johnson Roberts · 1 shared paper, 2024 · strength 0.15
  22. Janet E. Murphy · 1 shared paper, 2022 · strength 0.13
  23. Akhil Chawla · 1 shared paper, 2022 · strength 0.13
  24. Jon Michael Harrison · 1 shared paper, 2021 · strength 0.12
  25. Felipe Furtado · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.